The UK says AstraZeneca Shot Safe even after 7 blood clot deaths

Sign up here for our daily coronavirus newsletter on what you need to know and subscribe to our Covid-19 podcast for the latest news and reviews.

The UK has confirmed that seven people have died from rare blood clots after receiving them AstraZeneca Plc’s Covid-19 vaccine and Australia are also investigating a case of coagulation, raising questions about the safety of the widely used coronavirus fire.

Medicines in the UK and Health The product regulator said on Saturday that of the 30 cases of coagulation and low platelets identified in people in the UK who were shot by March 24, seven had died. More than 18 million doses have been administered in the country, and the regulator insists the shooting is safe.

“The benefits of the Covid-19 AstraZeneca vaccine in preventing Covid-19 infection and its complications continue to outweigh any risks, and the public should continue vaccination when asked to do so,” MHRA Executive Director June Raine said on Saturday. . an e-mail statement.

Australia said on Saturday it was cooperating with regulators in the UK and the European Union after a case of blood clotting was identified on April 2 in someone who received the AstraZeneca shot.

The latest revelation is likely to add to growing concern about the AstraZeneca vaccine, which is the backbone of the UK’s successful inoculation campaign. Many countries around the world have relied on AstraZeneca to run their immunization programs, and now some are reconsidering it, despite rising levels of Covid cases.

The Netherlands joined on Friday Germany has suspended the use of the vaccine in people under the age of 60. Norway and Denmark have extended suspensions over the use of the shot, which has also been the subject of confusion over supply between the EU, the UK and other countries.

South Africa on Friday ended the sale of 1 million photos to other countries after finding that they had little impact on a variant first identified in the country last year.

The UK continues to move forward with its vaccination program, which delivered a first blow to more than 60% of all adults. Prime Minister Boris Johnson has pledged to deliver a first blow to all adults by the end of July, with vaccination against Astra being key to achieving this goal.

Blood clots, anaphylaxis and other vaccine concerns: QuickTake

With the new reports on the state of coagulation, the rate of incidents following the shooting of AstraZeneca in the UK is about 1 in 600,000. No same vaccine reactions have been reported since Pfizer Inc. and BioNTech SE, which is also used in the UK.

Earlier this week, the EU medicines regulator said a link between the AstraZeneca vaccine and a rare type of blood clot was possible, identifying at least 62 cases of the condition. The European Medicines Agency said its safety committee is likely to issue an updated recommendation next week.

Although more research is needed to examine possible links, “the key thing to remember is how rare these brain clots are and how strong the proven benefit of vaccination against Covid is,” said David Werring, a professor of clinical neurology at the Institute. University of London. of Neurology.